BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8565228)

  • 1. Multicenter evaluation of the Abbott IMx CA 15-3 assay.
    van Kamp GJ; Bon GG; Verstraeten RA; Lynch D; Krikau M; Flückiger J; Ruibal A; Kenemans P
    Clin Chem; 1996 Jan; 42(1):28-33. PubMed ID: 8565228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
    Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
    Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 15-3: a multicentre evaluation of automated and manual tests.
    Huber PR; Bischof P; Kretschmer R; Truschnig M; Halwachs G; Schmidt M
    Eur J Clin Chem Clin Biochem; 1996 Jan; 34(1):77-84. PubMed ID: 8704042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.
    Lynch DM; Rogers PE; Love JC; Salkas MJ; Skarphol KA; Gross ME; Lu MG; Petrides VH; Bruzek DJ; Cox JL; Jones KA; Kelley CA; Chan DW
    Tumour Biol; 1998; 19(6):421-38. PubMed ID: 9817970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical and clinical evaluation of a procedure for measuring CA 15-3 in the IMx analyser.
    Ortega MD; Maestro ML; Encabo G; Varón C; Allende MT; Martinez I; Palacios G
    Tumour Biol; 1996; 17(2):110-6. PubMed ID: 8658013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
    Vessella RL; Noteboom J; Lange PH
    Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
    Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
    Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
    Bon GG; von Mensdorff-Pouilly S; Kenemans P; van Kamp GJ; Verstraeten RA; Hilgers J; Meijer S; Vermorken JB
    Clin Chem; 1997 Apr; 43(4):585-93. PubMed ID: 9105258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of micro particle enzyme immunoassay (MEIA) for the demonstration of antibody to hepatitis B surface antigen].
    Kashiwagi S; Hayashi J; Noguchi A; Nakashima K; Hirata M; Kajiyama W
    Kansenshogaku Zasshi; 1992 Mar; 66(3):390-9. PubMed ID: 1624829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated determination of human choriogonadotropin by use of microparticle capture analysis.
    Trundle DS; Chou PP; Raymond A
    Clin Chem; 1990 Mar; 36(3):554-6. PubMed ID: 2178804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Architect i2000 for determination of Scc with IMX determination of SCC with different methods.
    Serdarevic N; Stanciu AE
    Clin Lab; 2013; 59(9-10):1129-33. PubMed ID: 24273937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of the Bayer Immuno I CA 15-3 assay.
    Cheli CD; Morris DL; Kish L; Goldblatt J; Neaman I; Allard WJ; Yeung KK; Wu AH; Moore R; Chan DW; Fritsche HA; Schwartz MK; Very DL
    Clin Chem; 1998 Apr; 44(4):765-72. PubMed ID: 9554487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).
    Scholer A; Von Rickenbach R; Faffa G; Vetter B
    Clin Lab; 2006; 52(7-8):325-34. PubMed ID: 16955630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of MUC1 in breast cancer patients. A method comparison study.
    Bon GG; van Kamp GJ; Verstraeten RA; von Mensdorff-Pouilly S; Hilgers J; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):67-75. PubMed ID: 10221613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA.
    Pfeifer K; Dobson C; Herron A; Kapprell HP
    Clin Lab; 2002; 48(7-8):359-64. PubMed ID: 12146568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.
    Shahzad K; Kim DH; Kang MJ
    Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L; Tutor JC
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration.
    Mogensen O; Mogensen B
    Scand J Clin Lab Invest; 1995 Jul; 55(4):289-94. PubMed ID: 7569730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Abbott IMx fluorescence polarization immunoassay and the bio-rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography.
    Donnelly JG; Pronovost C
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():194-8. PubMed ID: 10735363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassay.
    Mogensen O; Mogensen B
    Scand J Clin Lab Invest; 1992 Oct; 52(6):507-12. PubMed ID: 1411262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.